Abstract
Alzheimer's disease is the most common neurodegenerative disorder that usually occurs after the age of 65 for which there is currently no cure. The predominant feature of this disease is the appearance of beta amyloid plaques next to the neurons in the brain. Numerous studies have investigated the possible causes of the disease and in particular the role of metals. In the present study, while briefly reviewing the effect of various lifestyle factors on the incidence and prevalence of the disease, by presenting the latest clinical reports and cohort studies regarding the role of metals in the disease, we try to provide a comprehensive overview of this issue to the reader. Some studies have shown changes in the concentration of metals in the brain or body fluids of AD patients, while others have not indicated any change. Therefore, it can be concluded that metals are not causative factor, but they are risk factor in certain conditions.
Similar content being viewed by others
References
P.A. Adlard, A.I. Bush, Metals and Alzheimer’s disease: how far have we come in the clinic? J. Alzheimer’s Dis. 62, 1369–1379 (2018). https://doi.org/10.3233/JAD-170662
C.J. Sarell, The Copper-Amyloid-Beta-Peptide Complex of Alzheimer’ s Disease : Affinity, Structure, Fibril Formation and Toxicity (University of London, London, 2010).
S. Bagheri, R. Squitti, T. Haertlé, M. Siotto, A.A. Saboury, Role of copper in the onset of Alzheimer’s disease compared to other metals. Front. Aging Neurosci. 9, 446 (2018). https://doi.org/10.3389/fnagi.2017.00446
X. Du, X. Wang, M. Geng, Alzheimer’s disease hypothesis and related therapies. Transl. Neurodegener. (2018). https://doi.org/10.1186/s40035-018-0107-y
M.A. Zoroddu, J. Aaseth, G. Crisponi, S. Medici, M. Peana, V.M. Nurchi, The essential metals for humans: a brief overview. J. Inorg. Biochem. 195, 120–129 (2019). https://doi.org/10.1016/J.JINORGBIO.2019.03.013
A.A.A. Saad, A. El-Sikaily, H. Kassem, Essential, non-essential metals and human health. Pollut. Status Environ. Prot. Renew. Energy Prod. Mar. Syst. 3, 47 (2016)
M. Jaishankar, T. Tseten, N. Anbalagan, B.B. Mathew, K.N. Beeregowda, Toxicity, mechanism and health effects of some heavy metals. Interdiscip. Toxicol. 7, 60–72 (2014). https://doi.org/10.2478/intox-2014-0009
S.G. Schäfer, W. Forth, Excretion of metals into the rat intestine. Biol. Trace Elem. Res. 5, 205–217 (1983). https://doi.org/10.1007/BF02916624
A.T. Jan, M. Azam, K. Siddiqui, A. Ali, I. Choi, Q.M.R. Haq, Heavy metals and human health: mechanistic insight into toxicity and counter defense system of antioxidants. Int. J. Mol. Sci. 16, 29592–29630 (2015). https://doi.org/10.3390/ijms161226183
S.J. Genuis, M. Sears, G. Schwalfenberg, J. Hope, R. Bernhoft, Incorporating environmental health in clinical medicine. J. Environ. Public Health. (2012). https://doi.org/10.1155/2012/103041
B. Dubois, H.H. Feldman, C. Jacova, H. Hampel, J.L. Molinuevo, K. Blennow, S.T. Dekosky, S. Gauthier, D. Selkoe, R. Bateman, S. Cappa, S. Crutch, S. Engelborghs, G.B. Frisoni, N.C. Fox, D. Galasko, M.O. Habert, G.A. Jicha, A. Nordberg, F. Pasquier, G. Rabinovici, P. Robert, C. Rowe, S. Salloway, M. Sarazin, S. Epelbaum, L.C. de Souza, B. Vellas, P.J. Visser, L. Schneider, Y. Stern, P. Scheltens, J.L. Cummings, Advancing research diagnostic criteria for Alzheimer’s disease: The IWG-2 criteria. Lancet Neurol. (2014). https://doi.org/10.1016/S1474-4422(14)70090-0
A.M. Fernandez, A. Santi, I. Torres Aleman, Insulin peptides as mediators of the impact of life style in Alzheimer’s disease. Brain Plast. 4, 3–15 (2018). https://doi.org/10.3233/bpl-180071
M. Baumgart, H.M. Snyder, M.C. Carrillo, S. Fazio, H. Kim, H. Johns, Summary of the evidence on modifiable risk factors for cognitive decline and dementia: a population-based perspective. Alzheimer’s Dement. 11, 718–726 (2015). https://doi.org/10.1016/j.jalz.2015.05.016
M. Crous-Bou, C. Minguillón, N. Gramunt, J.L. Molinuevo, Alzheimer’s disease prevention: from risk factors to early intervention. Alzheimer’s Res. Ther. 9, 71 (2017). https://doi.org/10.1186/s13195-017-0297-z
M.L. Daviglus, C.C. Bell, W. Berrettini, P.E. Bowen, E.S. Connolly, N.J. Cox, J.M. Dunbar-Jacob, E.C. Granieri, G. Hunt, K. McGarry, D. Patel, A.L. Potosky, E. Sanders-Bush, D. Silberberg, M. Trevisan, National Institutes of Health state-of-the-science conference statement: preventing Alzheimer disease and cognitive decline. Ann. Intern. Med. 153, 176–181 (2010). https://doi.org/10.7326/0003-4819-153-3-201008030-00260
D.E. Barnes, K. Yaffe, The projected impact of risk factor reduction on Alzheimer’s disease prevalence. Lancet Neurol. 10, 819–828 (2011). https://doi.org/10.1016/S1474-4422(11)70072-2
B.R. Cardoso, C. Cominetti, S.M.F. Cozzolino, Importance and management of micronutrient deficiencies in patients with Alzheimer’s disease. Clin. Interv. Aging. 8, 531–542 (2013). https://doi.org/10.2147/CIA.S27983
A.G. Pacholko, C.A. Wotton, L.K. Bekar, Poor diet, stress, and inactivity converge to form a “Perfect Storm” that drives Alzheimer’s disease pathogenesis. Neurodegener. Dis. 19, 60–77 (2019). https://doi.org/10.1159/000503451
R.F. Gottesman, A.L.C. Schneider, Y. Zhou, J. Coresh, E. Green, N. Gupta, D.S. Knopman, A. Mintz, A. Rahmim, A.R. Sharrett, L.E. Wagenknecht, D.F. Wong, T.H. Mosley, Association between midlife vascular risk factors and estimated brain amyloid deposition. JAMA J. Am. Med. Assoc. (2017). https://doi.org/10.1001/jama.2017.3090
J.K. Cataldo, J.J. Prochaska, S.A. Glantz, Cigarette smoking is a risk factor for Alzheimer’s disease: an analysis controlling for tobacco industry affiliation. J. Alzheimer’s Dis. 19, 465–480 (2010). https://doi.org/10.3233/JAD-2010-1240
C. Wallin, S.B. Sholts, N. Österlund, J. Luo, J. Jarvet, P.M. Roos, L. Ilag, A. Gräslund, S.K.T.S. Wärmländer, Alzheimer’s disease and cigarette smoke components: effects of nicotine, PAHs, and Cd(II), Cr(III), Pb(II), Pb(IV) ions on amyloid-β peptide aggregation. Sci. Rep. 7, 14423 (2017). https://doi.org/10.1038/s41598-017-13759-5
D. Laurin, R. Verreault, J. Lindsay, K. MacPherson, K. Rockwood, Physical activity and risk of cognitive impairment and dementia in elderly persons. Arch. Neurol. 58, 498–504 (2001). https://doi.org/10.1001/archneur.58.3.498
L.J. Podewils, E. Guallar, L.H. Kuller, L.P. Fried, O.L. Lopez, M. Carlson, C.G. Lyketsos, Physical activity, APOE genotype, and dementia risk: findings from the cardiovascular health cognition study. Am. J. Epidemiol. 161, 639–651 (2005). https://doi.org/10.1093/aje/kwi092
Y. Rolland, G. Abellan van Kan, B. Vellas, Physical activity and Alzheimer’s disease: from prevention to therapeutic perspectives. J. Am. Med. Dir. Assoc. 9, 390–405 (2008). https://doi.org/10.1016/j.jamda.2008.02.007
S. Sabia, A. Dugravot, J.F. Dartigues, J. Abell, A. Elbaz, M. Kivimäki, A. Singh-Manoux, Physical activity, cognitive decline, and risk of dementia: 28 year follow-up of Whitehall II cohort study. BMJ 357, j2709 (2017). https://doi.org/10.1136/bmj.j2709
M. Weih, J. Wiltfang, J. Kornhuber, Non-pharmacologic prevention of Alzheimer’s disease: nutritional and life-style risk factors. J. Neural Transm. 114, 1187–1197 (2007). https://doi.org/10.1007/s00702-007-0704-x
A. Mendonça, R.A. Cunha, Therapeutic opportunities for caffeine in Alzheimer’s disease and other neurodegenerative disorders. J. Alzheimer’s Dis. (2010). https://doi.org/10.3233/JAD-2010-01420
V. Flaten, C. Laurent, J.E. Coelho, U. Sandau, V.L. Batalha, S. Burnouf, M. Hamdane, S. Humez, D. Boison, L.V. Lopes, L. Buée, D. Blum, From epidemiology to pathophysiology: what about caffeine in Alzheimer’s disease? Biochem. Soc. Trans. 42, 587–592 (2014). https://doi.org/10.1042/BST20130229
Y. Chern, N. Rei, J.A. Ribeiro, A.M. Sebastião, Adenosine and its receptors as potential drug targets in amyotrophic lateral sclerosis. J. Caffeine Adenosine Res. 9, 157–166 (2019). https://doi.org/10.1089/caff.2019.0016
S.F. Akomolafe, The effects of caffeine, caffeic acid, and their combination on acetylcholinesterase, adenosine deaminase and arginase activities linked with brain function. J. Food Biochem. 41, e12401 (2017). https://doi.org/10.1111/jfbc.12401
S.F. Akomolafe, A.J. Akinyemi, O.B. Ogunsuyi, S.I. Oyeleye, G. Oboh, O.O. Adeoyo, Y.R. Allismith, Effect of caffeine, caffeic acid and their various combinations on enzymes of cholinergic, monoaminergic and purinergic systems critical to neurodegeneration in rat brain—in vitro. Neurotoxicology. 62, 6–13 (2017). https://doi.org/10.1016/j.neuro.2017.04.008
K. Sharma, Cholinesterase inhibitors as Alzheimer’s therapeutics (Review). Mol. Med. Rep. 20, 1479–1487 (2019). https://doi.org/10.3892/mmr.2019.10374
S. Bagheri, A.A. Saboury, T. Haertlé, Adenosine deaminase inhibition. Int. J. Biol. Macromol. 141, 1246–1257 (2019). https://doi.org/10.1016/j.ijbiomac.2019.09.078
G. Ataie, S. Bagheri, A. Divsalar, A.A. Saboury, S. Safarian, S. Namaki, A.A. Moosavi-Movahedi, A kinetic comparison on the inhibition of adenosine deaminase by purine drugs. Iran. J. Pharm. Res. 6, 43–50 (2007)
S.V. Ovsepian, V.B. O’Leary, Can arginase inhibitors be the answer to therapeutic challenges in Alzheimer’s disease? Neurotherapeutics. 15, 1032–1035 (2018). https://doi.org/10.1007/s13311-018-0668-6
Y. Manivannan, B. Manivannan, T. Beach, R. Halden, Role of environmental contaminants in the etiology of Alzheimers disease: a review. Curr. Alzheimer Res. 12, 116–146 (2015). https://doi.org/10.2174/1567205012666150204121719
A.R. Armstrong, Risk factors for Alzheimer’s disease. Folia Neuropathol. 57, 87–105 (2019). https://doi.org/10.5114/fn.2019.85929
F. Li, Z. Qiu, J. Zhang, W. Liu, C. Liu, G. Zeng, Investigation, pollution mapping and simulative leakage health risk assessment for heavy metals and metalloids in groundwater from a typical brownfield, middle China. Int. J. Environ. Res. Public Health. 14, 768 (2017). https://doi.org/10.3390/ijerph14070768
G. Azeh Engwa, P. Udoka Ferdinand, F. Nweke Nwalo, M. N. Unachukwu, Mechanism and Health Effects of Heavy Metal Toxicity in Humans, in Poisoning Mod World New Tricks an Old Dog? (2019). https://doi.org/10.5772/intechopen.82511.
P. Chen, M.R. Miah, M. Aschner, Metals and Neurodegeneration. F1000Research. (2016). https://doi.org/10.12688/f1000research.7431.1
WHO, Trace elements in human nutrition and health World Health Organization, World Heal. Organ. (1996).
E. Inan-Eroglu, A. Ayaz, Is aluminum exposure a risk factor for neurological disorders? J. Res. Med. Sci. 2018, 23–51 (2018). https://doi.org/10.4103/jrms.JRMS_921_17
Y.K. Gupta, M. Meenu, S.S. Peshin, Aluminium utensils: Is it a concern? Natl. Med. J. India. 32, 38–40 (2019). https://doi.org/10.4103/0970-258X.272116
D. Dordevic, H. Buchtova, S. Jancikova, B. Macharackova, M. Jarosova, T. Vitez, I. Kushkevych, Aluminum contamination of food during culinary preparation: case study with aluminum foil and consumers’ preferences. Food Sci. Nutr. 7, 3349–3360 (2019). https://doi.org/10.1002/fsn3.1204
S.A. Virk, G.D. Eslick, Brief report: meta-analysis of antacid use and Alzheimer’s disease: implications for the aluminum hypothesis. Epidemiology. 26, 769–773 (2015). https://doi.org/10.1097/EDE.0000000000000326
T.I. Lidsky, Is the aluminum hypothesis dead? J. Occup. Environ. Med. 56, 73–79 (2014). https://doi.org/10.1097/JOM.0000000000000063
D.L. Marcus, D.L. Wong, M.L. Freedman, Dietary aluminum and alzheimer’s disease. J. Nutr. Elder. 12, 55–61 (1992). https://doi.org/10.1300/J052v12n02_04
H.P. Carr, E. Lombi, H. Küpper, S.P. McGrath, M.H. Wong, Accumulation and distribution of aluminium and other elements in tea (Camellia sinensis) leaves. Agronomie. 23, 705–710 (2003). https://doi.org/10.1051/agro:2003045
S. Kakutani, H. Watanabe, N. Murayama, Green tea intake and risks for dementia, Alzheimer’s disease, mild cognitive impairment, and cognitive impairment: a systematic review. Nutrients. 11, 1165 (2019). https://doi.org/10.3390/nu11051165
M. Noguchi-Shinohara, S. Yuki, C. Dohmoto, Y. Ikeda, M. Samuraki, K. Iwasa, M. Yokogawa, K. Asai, K. Komai, H. Nakamura, M. Yamada, Consumption of green tea, but not black tea or coffee, is associated with reduced risk of cognitive decline. PLoS ONE 9, e96013 (2014). https://doi.org/10.1371/journal.pone.0096013
C.A. Polito, Z.Y. Cai, Y.L. Shi, X.M. Li, R. Yang, M. Shi, Q.S. Li, S.C. Ma, L.P. Xiang, K.R. Wang, J.H. Ye, J.L. Lu, X.Q. Zheng, Y.R. Liang, Association of tea consumption with risk of alzheimer’s disease and anti-beta-amyloid effects of tea. Nutrients. 10, 655 (2018). https://doi.org/10.3390/nu10050655
S.C. Sofuoglu, P. Kavcar, An exposure and risk assessment for fluoride and trace metals in black tea. J. Hazard. Mater. 158, 392–400 (2008). https://doi.org/10.1016/j.jhazmat.2008.01.086
T. Fei, J. Fei, F. Huang, T. Xie, J. Xu, Y. Zhou, P. Yang, The anti-aging and anti-oxidation effects of tea water extract in Caenorhabditis elegans. Exp. Gerontol. 97, 89–96 (2017). https://doi.org/10.1016/j.exger.2017.07.015
S. Peters, A. Reid, L. Fritschi, N. De Klerk, A.W. Musk, Long-term effects of aluminium dust inhalation. Occup. Environ. Med. (2013). https://doi.org/10.1136/oemed-2013-101487
S.A. Virk, G.D. Eslick, Occupational exposure to aluminum and Alzheimer disease a meta-analysis. J. Occup. Environ. Med. 57, 893–896 (2015). https://doi.org/10.1097/JOM.0000000000000487
S. Meshitsuka, D.A. Aremu, T. Nose, A risk of Alzheimer’s disease and aluminum in drinking water. Psychogeriatrics. 2, 263–268 (2002). https://doi.org/10.1111/j.1479-8301.2002.tb00039.x
V. Rondeau, H. Jacqmin-Gadda, D. Commenges, C. Helmer, J.F. Dartigues, Aluminum and silica in drinking water and the risk of Alzheimer’s disease or cognitive decline: findings from 15-year follow-up of the PAQUID cohort. Am. J. Epidemiol. 169, 489–496 (2009). https://doi.org/10.1093/aje/kwn348
C.N. Martyn, D.N. Coggon, H. Inskip, R.F. Lacey, W.F. Young, Aluminum concentrations in drinking water and risk of Alzheimer’s disease. Epidemiology. 8, 281–286 (1997). https://doi.org/10.1097/00001648-199705000-00009
D.P. Forster, A.J. Newens, D.W.K. Kay, J.A. Edwardson, Risk factors in clinically diagnosed presenile dementia of the Alzheimer type: A case-control study in northern England. J. Epidemiol. Community Health. 49, 253–258 (1995). https://doi.org/10.1136/jech.49.3.253
G.A. Taylor, A.J. Newens, J.A. Edwardson, D.W.K. Kay, D.P. Forster, Alzheimer’s disease and the relationship between silicon and aluminium in water supplies in northern England. J. Epidemiol. Community Health. 49, 323–324 (1995). https://doi.org/10.1136/jech.49.3.323
X.L. Shen, J.H. Yu, D.F. Zhang, J.X. Xie, H. Jiang, Positive relationship between mortality from Alzheimer’s disease and soil metal concentration in mainland China. J. Alzheimer’s Dis. 42, 893–900 (2014). https://doi.org/10.3233/JAD-140153
Z. Wang, X. Wei, J. Yang, J. Suo, J. Chen, X. Liu, X. Zhao, Chronic exposure to aluminum and risk of Alzheimer’s disease: a meta-analysis. Neurosci. Lett. 610, 200–206 (2016). https://doi.org/10.1016/j.neulet.2015.11.014
A. Mirza, A. King, C. Troakes, C. Exley, Aluminium in brain tissue in familial Alzheimer’s disease. J. Trace Elem. Med. Biol. 40, 30–36 (2017). https://doi.org/10.1016/j.jtemb.2016.12.001
S. Yumoto, S. Kakimi, A. Ohsaki, A. Ishikawa, Demonstration of aluminum in amyloid fibers in the cores of senile plaques in the brains of patients with Alzheimer’s disease. J. Inorg. Biochem. 103, 1579–1584 (2009). https://doi.org/10.1016/j.jinorgbio.2009.07.023
S. Bhattacharjee, Y. Zhao, J.M. Hill, F. Culicchia, T.P.A. Kruck, M.E. Percy, A.I. Pogue, J.R. Walton, W.J. Lukiw, Selective accumulation of aluminum in cerebral arteries in alzheimer’s disease (ad). J. Inorg. Biochem. 126, 35–37 (2013). https://doi.org/10.1016/j.jinorgbio.2013.05.007
L.M. Gaetke, H.S. Chow-Johnson, C.K. Chow, Copper: toxicological relevance and mechanisms. Arch. Toxicol. 88, 1929–1938 (2014). https://doi.org/10.1007/s00204-014-1355-y
I. of Medicine, Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc (2001). https://doi.org/10.17226/10026.
A.A. Taylor, J.S. Tsuji, M.R. Garry, M.E. McArdle, W.L. Goodfellow, W.J. Adams, C.A. Menzie, Critical review of exposure and effects: implications for setting regulatory health criteria for ingested copper. Environ. Manage. 65, 131–159 (2020). https://doi.org/10.1007/s00267-019-01234-y
M.J. Ceko, J.B. Aitken, H.H. Harris, Speciation of copper in a range of food types by X-ray absorption spectroscopy. Food Chem. 164, 50–54 (2014). https://doi.org/10.1016/j.foodchem.2014.05.018
R.S. Ohgami, D.R. Campagna, A. McDonald, M.D. Fleming, The Steap proteins are metalloreductases. Blood 108, 1388–1394 (2006). https://doi.org/10.1182/blood-2006-02-003681
P.V.E. Van Den Berghe, L.W.J. Klomp, New developments in the regulation of intestinal copper absorption. Nutr. Rev. 67, 658–672 (2009). https://doi.org/10.1111/j.1753-4887.2009.00250.x
M. Bost, S. Houdart, M. Oberli, E. Kalonji, J.F. Huneau, I. Margaritis, Dietary copper and human health: Current evidence and unresolved issues. J. Trace Elem. Med. Biol. 35, 107–115 (2016). https://doi.org/10.1016/j.jtemb.2016.02.006
H. Kessler, F.-G. Pajonk, D. Bach, T. Schneider-Axmann, P. Falkai, W. Herrmann, G. Multhaup, J. Wiltfang, S. Schafer, O. Wirths, T.A. Bayer, Effect of copper intake on CSF parameters in patients with mild Alzheimer’s disease: a pilot phase 2 clinical trial. J. Neural Transm. 115, 1181–1187 (2008). https://doi.org/10.1007/s00702-008-0080-1
M.C. Morris, D.A. Evans, C.C. Tangney, J.L. Bienias, J.A. Schneider, R.S. Wilson, P.A. Scherr, Dietary copper and high saturated and trans fat intakes associated with cognitive decline. Arch. Neurol. 63, 1085–1088 (2006). https://doi.org/10.1001/archneur.63.8.1085
G.J. Brewer, Copper toxicity in Alzheimer’s disease: cognitive loss from ingestion of inorganic copper. J. Trace Elem. Med. Biol. 26, 89–92 (2012). https://doi.org/10.1016/j.jtemb.2012.04.019
G.J. Brewer, S.H. Kanzer, E.A. Zimmerman, D.F. Celmins, S.M. Heckman, R. Dick, Copper and ceruloplasmin abnormalities in Alzheimer’s disease. Am. J. Alzheimers. Dis. Other Demen. 25, 490–497 (2010). https://doi.org/10.1177/1533317510375083
G.R. Behbehani, L. Barzegar, M. Mohebbian, A.A. Saboury, A comparative interaction between copper ions with Alzheimer’s amyloid peptide and human serum albumin. Bioinorg. Chem. Appl. (2012). https://doi.org/10.1155/2012/208641
H.W. Hsu, S.C. Bondy, M. Kitazawa, Environmental and dietary exposure to copper and its cellular mechanisms linking to Alzheimer’s disease. Toxicol. Sci. 163, 338–345 (2018). https://doi.org/10.1093/toxsci/kfy025
I. Singh, A.P. Sagare, M. Coma, D. Perlmutter, R. Gelein, R.D. Bell, R.J. Deane, E. Zhong, M. Parisi, J. Ciszewski, R.T. Kasper, R. Deane, Low levels of copper disrupt brain amyloid-β homeostasis by altering its production and clearance. Proc. Natl. Acad. Sci. 110, 14771–14776 (2013). https://doi.org/10.1073/pnas.1302212110
L. Pickart, J.M. Vasquez-Soltero, A. Margolina, The effect of the human peptide GHK on gene expression relevant to nervous system function and cognitive decline. Brain Sci. 7, 20 (2017). https://doi.org/10.3390/brainsci7020020
S.J. Bhathena, L. Recant, N.R. Voyles, K.I. Timmers, S. Reiser, J.C. Smith, A.S. Powell, Decreased plasma enkephalins in copper deficiency in man. Am. J. Clin. Nutr. 43, 42–46 (1986). https://doi.org/10.1093/ajcn/43.1.42
E.L. Sampson, N. White, K. Lord, B. Leurent, V. Vickerstaff, S. Scott, L. Jones, Pain, agitation, and behavioural problems in people with dementia admitted to general hospital wards: a longitudinal cohort study. Pain 156, 675–683 (2015). https://doi.org/10.1097/j.pain.0000000000000095
Z. Cai, A. Ratka, Opioid system and Alzheimer’s disease. Neuromol. Med. 14, 91–111 (2012). https://doi.org/10.1007/s12017-012-8180-3
L. Pirpamer, E. Hofer, B. Gesierich, F. De Guio, P. Freudenberger, S. Seiler, M. Duering, E. Jouvent, E. Duchesnay, M. Dichgans, S. Ropele, R. Schmidt, Determinants of iron accumulation in the normal aging brain. Neurobiol. Aging. 43, 149–155 (2016). https://doi.org/10.1016/j.neurobiolaging.2016.04.002
J. Stankiewicz, S.S. Panter, M. Neema, A. Arora, C.E. Batt, R. Bakshi, Iron in chronic brain disorders: imaging and neurotherapeutic implications. Neurotherapeutics. 4, 371–386 (2007). https://doi.org/10.1016/j.nurt.2007.05.006
B.B. Yavuz, M. Cankurtaran, I.C. Haznedaroglu, M. Halil, Z. Ulger, B. Altun, S. Ariogul, Iron deficiency can cause cognitive impairment in geriatric patients. J. Nutr. Heal. Aging. 16, 220–224 (2012). https://doi.org/10.1007/s12603-011-0351-7
P.K. Lam, D. Kritz-Silverstein, E. Barrett-Connor, D. Milne, F. Nielsen, A. Gamst, D. Morton, D. Wingard, Plasma trace elements and cognitive function in older men and women: the Rancho Bernardo study. J. Nutr. Heal. Aging. 12, 22–27 (2008). https://doi.org/10.1007/BF02982160
R.C. Shah, A.S. Buchman, R.S. Wilson, S.E. Leurgans, D.A. Bennett, Hemoglobin level in older persons and incident Alzheimer disease prospective cohort analysis. Neurology. 77, 219–226 (2011). https://doi.org/10.1212/WNL.0b013e318225aaa9
D.D. Li, W. Zhang, Z.Y. Wang, P. Zhao, Serum copper, zinc, and iron levels in patients with Alzheimer’s disease: a meta-analysis of case-control studies. Front. Aging Neurosci. 15, 300 (2017). https://doi.org/10.3389/fnagi.2017.00300
A. Damulina, L. Pirpamer, M. Soellradl, M. Sackl, C. Tinauer, E. Hofer, C. Enzinger, B. Gesierich, M. Duering, S. Ropele, R. Schmidt, C. Langkammer, Cross-sectional and longitudinal assessment of brain iron level in Alzheimer disease using 3-T MRI. Radiology 296, 619–626 (2020). https://doi.org/10.1148/radiol.2020192541
S. Ayton, Y. Wang, I. Diouf, J.A. Schneider, J. Brockman, M.C. Morris, A.I. Bush, Brain iron is associated with accelerated cognitive decline in people with Alzheimer pathology. Mol. Psychiatry. 25, 2932–2941 (2020). https://doi.org/10.1038/s41380-019-0375-7
J. Everett, J. Brooks, F. Lermyte, P.B. O’Connor, P.J. Sadler, J. Dobson, J.F. Collingwood, N.D. Telling, Iron stored in ferritin is chemically reduced in the presence of aggregating Aβ(1–42). Sci. Rep. 10, 10332 (2020). https://doi.org/10.1038/s41598-020-67117-z
Z. Xie, H. Wu, J. Zhao, Multifunctional roles of zinc in Alzheimer’s disease. Neurotoxicology. 80, 112–123 (2020). https://doi.org/10.1016/j.neuro.2020.07.003
S.D. Gower-Winter, C.W. Levenson, Zinc in the central nervous system: From molecules to behavior. BioFactors 38, 186–193 (2012). https://doi.org/10.1002/biof.1012
J. Chaudhary, R. Jora, P. Sharma, R. Gehlot, A study of iron and zinc deficiency on short term memory in children & effect of their supplementation. Asian J. Biomed. Pharm. Sci. 5, 12–15 (2015). https://doi.org/10.15272/ajbps.v5i42.664
J.E. De Moura, E.N.O. De Moura, C.X. Alves, S.H. De Lima Vale, M.M.G. Dantas, A. De Araújo Silva, M. Das Graças Almeida, L.D. Leite, J. Brandão-Neto, Oral zinc supplementation may improve cognitive function in schoolchildren. Biol. Trace Elem. Res. 155, 23–28 (2013). https://doi.org/10.1007/s12011-013-9766-9
E. Khodashenas, A. Mohammadzadeh, M. Sohrabi, A. Izanloo, The effect of zinc supplementation on cognitive performance in schoolchildren. Int. J. Pediatr. 3, 1033–1038 (2015). https://doi.org/10.22038/ijp.2015.5617
R.P. Tupe, S.A. Chiplonkar, Zinc supplementation improved cognitive performance and taste acuity in indian adolescent girls. J. Am. Coll. Nutr. 28, 388–396 (2009). https://doi.org/10.1080/07315724.2009.10718101
Y. Xu, G. Xiao, L. Liu, M. Lang, Zinc transporters in Alzheimer’s disease. Mol. Brain. 12, 1–12 (2019). https://doi.org/10.1186/s13041-019-0528-2
V. Tõugu, A. Karafin, K. Zovo, R.S. Chung, C. Howells, A.K. West, P. Palumaa, Zn(II)- and Cu(II)-induced non-fibrillar aggregates of amyloid-β (1–42) peptide are transformed to amyloid fibrils, both spontaneously and under the influence of metal chelators. J. Neurochem. 110, 1784–1795 (2009). https://doi.org/10.1111/j.1471-4159.2009.06269.x
J. Mutter, A. Curth, J. Naumann, R. Deth, H. Walach, Does inorganic mercury play a role in Alzheimer’s disease? A systematic review and an integrated molecular mechanism. J. Alzheimer’s Dis. 22, 357–374 (2010). https://doi.org/10.3233/JAD-2010-100705
T. Sanders, Y. Liu, V. Buchner, P.B. Tchounwou, Neurotoxic effects and biomarkers of lead exposure: a review. Rev. Environ. Health. 24, 15–45 (2009). https://doi.org/10.1515/REVEH.2009.24.1.15
T.W. Clarkson, L. Magos, G.J. Myers, The toxicology of mercury—current exposures and clinical manifestations. N. Engl. J. Med. 349, 1731–1737 (2003). https://doi.org/10.1056/NEJMra022471
M.R. Basha, W. Wei, S.A. Bakheet, N. Benitez, H.K. Siddiqi, Y.W. Ge, D.K. Lahiri, N.H. Zawia, The fetal basis of amyloidogenesis: exposure to lead and latent overexpression of amyloid precursor protein and β-amyloid in the aging brain. J. Neurosci. 25, 823–829 (2005). https://doi.org/10.1523/JNEUROSCI.4335-04.2005
J. Wu, M.R. Basha, B. Brock, D.P. Cox, F. Cardozo-Pelaez, C.A. McPherson, J. Harry, D.C. Rice, B. Maloney, D. Chen, D.K. Lahiri, N.H. Zawia, Alzheimer’s Disease (AD)-like pathology in aged monkeys after infantile exposure to environmental metal lead (Pb): evidence for a developmental origin and environmental link for AD. J. Neurosci. 28, 3–9 (2008). https://doi.org/10.1523/JNEUROSCI.4405-07.2008
S.W. Bihaqi, Early life exposure to lead (Pb) and changes in DNA methylation: relevance to Alzheimer’s disease. Rev. Environ. Health. (2019). https://doi.org/10.1515/reveh-2018-0076
L.H. Mason, J.P. Harp, D.Y. Han, Pb neurotoxicity: Neuropsychological effects of lead toxicity. Biomed. Res. Int. 2014, 840547 (2014). https://doi.org/10.1155/2014/840547
H. Gu, P.R. Territo, S.A. Persohn, A.A. Bedwell, K. Eldridge, R. Speedy, Z. Chen, W. Zheng, Y. Du, Evaluation of chronic lead effects in the blood brain barrier system by DCE-CT. J. Trace Elem. Med. Biol. 62, 126648 (2020). https://doi.org/10.1016/j.jtemb.2020.126648
X. Shen, L. Xia, L. Liu, H. Jiang, J. Shannahan, Y. Du, W. Zheng, Altered clearance of beta-amyloid from the cerebrospinal fluid following subchronic lead exposure in rats: Roles of RAGE and LRP1 in the choroid plexus. J. Trace Elem. Med. Biol. 61, 126520 (2020). https://doi.org/10.1016/j.jtemb.2020.126520
D.J. Hare, N.G. Faux, B.R. Roberts, I. Volitakis, R.N. Martins, A.I. Bush, Lead and manganese levels in serum and erythrocytes in Alzheimer’s disease and mild cognitive impairment: results from the Australian Imaging, biomarkers and lifestyle Flagship study of ageing. Metallomics (2016). https://doi.org/10.1039/c6mt00019c
L. Xu, W. Zhang, X. Liu, C. Zhang, P. Wang, X. Zhao, Circulatory levels of toxic metals (aluminum, cadmium, mercury, lead) in patients with Alzheimer’s disease: a quantitative meta-analysis and systematic review. J. Alzheimer’s Dis. 62, 361–372 (2018). https://doi.org/10.3233/JAD-170811
B.R. Roberts, T.M. Ryan, A.I. Bush, C.L. Masters, J.A. Duce, The role of metallobiology and amyloid-β peptides in Alzheimer’s disease. J. Neurochem. 120, 149–166 (2012). https://doi.org/10.1111/j.1471-4159.2011.07500.x
C. Wallin, M. Friedemann, S.B. Sholts, A. Noormägi, T. Svantesson, J. Jarvet, P.M. Roos, P. Palumaa, A. Gräslund, S.K.T.S. Wärmländer, Mercury and alzheimer’s disease: Hg(II) ions display specific binding to the amyloid-β peptide and hinder its fibrillization. Biomolecules. 10, 44 (2020). https://doi.org/10.3390/biom10010044
D. Meleleo, G. Notarachille, V. Mangini, F. Arnesano, Concentration-dependent effects of mercury and lead on Aβ42: possible implications for Alzheimer’s disease. Eur. Biophys. J. 48, 173–187 (2019). https://doi.org/10.1007/s00249-018-1344-9
D.A. Geier, J.K. Kern, K.G. Homme, M.R. Geier, A cross-sectional study of blood ethylmercury levels and cognitive decline among older adults and the elderly in the United States. J. Alzheimer’s Dis. 72, 901–910 (2019). https://doi.org/10.3233/JAD-190894
G. Bjørklund, A.A. Tinkov, M. Dadar, M.M. Rahman, S. Chirumbolo, A.V. Skalny, M.G. Skalnaya, B.E. Haley, O.P. Ajsuvakova, J. Aaseth, Insights into the Potential Role of Mercury in Alzheimer’s Disease. J. Mol. Neurosci. 67, 511–533 (2019). https://doi.org/10.1007/s12031-019-01274-3
G. Bjørklund, B. Hilt, M. Dadar, U. Lindh, J. Aaseth, Neurotoxic effects of mercury exposure in dental personnel. Basic Clin. Pharmacol. Toxicol. 124, 568–574 (2019). https://doi.org/10.1111/bcpt.13199
N. Nagpal, S.S. Bettiol, A. Isham, H. Hoang, L.A. Crocombe, A review of mercury exposure and health of dental personnel. Saf. Health Work. 8, 1–10 (2017). https://doi.org/10.1016/j.shaw.2016.05.007
N. Attiya, R. Fattahi, A. El-Haidani, N. Lahrach, M.Y. Amarouch, Y. Filali-Zegzouti, Mercury exposure and dentists’ health status in two regions of centrall Morocco: Descriptive cross-sectional survey. Pan Afr. Med. J. 36, 1–13 (2020). https://doi.org/10.11604/pamj.2020.36.110.19623
N. Mikhailichenko, K. Yagami, J.Y. Chiou, J.Y. Huang, Y.H. Wang, J.C.C. Wei, T.J. Lai, Exposure to dental filling materials and the risk of dementia: a population-based nested case control study in Taiwan. Int. J. Environ. Res. Public Health. 16, 3283 (2019). https://doi.org/10.3390/ijerph16183283
R. Siblerud, J. Mutter, E. Moore, J. Naumann, H. Walach, A hypothesis and evidence that mercury may be an etiological factor in alzheimer’s disease. Int. J. Environ. Res. Public Health. 16, 5152 (2019). https://doi.org/10.3390/ijerph16245152
B.A. Racette, M. Aschner, T.R. Guilarte, U. Dydak, S.R. Criswell, W. Zheng, Pathophysiology of manganese-associated neurotoxicity. Neurotoxicology. 33, 881–886 (2012). https://doi.org/10.1016/j.neuro.2011.12.010
A.W. Dobson, K.M. Erikson, M. Aschner, Manganese neurotoxicity. Ann. N. Y. Acad. Sci. 1012, 115–128 (2004). https://doi.org/10.1196/annals.1306.009
M.A. Verity, Manganese neurotoxicity: a mechanistic hypothesis. Neurotoxicology. 20, 489–497 (1999)
K. Du, M. Liu, Y. Pan, X. Zhong, M. Wei, Association of serum manganese levels with Alzheimer’s disease and mild cognitive impairment: a systematic review and meta-analysis. Nutrients. 9, 231 (2017). https://doi.org/10.3390/nu9030231
L. Gerhardsson, T. Lundh, L. Minthon, E. Londos, Metal concentrations in plasma and cerebrospinal fluid in patients with Alzheimer’s disease. Dement. Geriatr. Cogn. Disord. 25, 508–515 (2008). https://doi.org/10.1159/000129365
I.M. Balmu, S.A. Strungaru, A. Ciobica, M.N. Nicoara, R. Dobrin, G. Plavan, C. Tefǎnescu, Preliminary data on the interaction between some biometals and oxidative stress status in mild cognitive impairment and Alzheimer’s disease patients. Oxid. Med. Cell. Longev. 2017, 7156928 (2017). https://doi.org/10.1155/2017/7156928
D.B. Milne, R.L. Sims, N.V.C. Ralston, Manganese content of the cellular components of blood. Clin. Chem. 36, 450–452 (1990). https://doi.org/10.1093/clinchem/36.3.450
Y. Tong, H. Yang, X. Tian, H. Wang, T. Zhou, S. Zhang, J. Yu, T. Zhang, D. Fan, X. Guo, T. Tabira, F. Kong, Z. Chen, W. Xiao, D. Chui, High manganese, a risk for Alzheimer’s disease: high manganese induces amyloid-β related cognitive impairment. J. Alzheimer’s Dis. 42, 865–878 (2014). https://doi.org/10.3233/JAD-140534
D. Gandhi, S. Sivanesan, K. Kannan, Manganese-induced neurotoxicity and alterations in gene expression in human neuroblastoma SH-SY5Y cells. Biol. Trace Elem. Res. 183, 245–253 (2018). https://doi.org/10.1007/s12011-017-1153-5
V. Venkataramani, T.R. Doeppner, D. Willkommen, C.M. Cahill, Y. Xin, G. Ye, Y. Liu, A. Southon, A. Aron, H.Y. Au-Yeung, X. Huang, D.K. Lahiri, F. Wang, A.I. Bush, G.G. Wulf, P. Ströbel, B. Michalke, J.T. Rogers, Manganese causes neurotoxic iron accumulation via translational repression of amyloid precursor protein and H-Ferritin. J. Neurochem. 147, 831–848 (2018). https://doi.org/10.1111/jnc.14580
A.C. Martins, P. Morcillo, O.M. Ijomone, V. Venkataramani, F.E. Harrison, E. Lee, A.B. Bowman, M. Aschner, New insights on the role of manganese in alzheimer’s disease and parkinson’s disease. Int. J. Environ. Res. Public Health. 16, 3546 (2019). https://doi.org/10.3390/ijerph16193546
H. Vural, H. Demirin, Y. Kara, I. Eren, N. Delibas, Alterations of plasma magnesium, copper, zinc, iron and selenium concentrations and some related erythrocyte antioxidant enzyme activities in patients with Alzheimer’s disease. J. Trace Elem. Med. Biol. 24, 169–173 (2010). https://doi.org/10.1016/j.jtemb.2010.02.002
A.E. Çilliler, Ş Öztürk, Ş Özbakır, Serum magnesium level and clinical deterioration in Alzheimer’s disease. Gerontology. 53, 419–422 (2007). https://doi.org/10.1159/000110873
E. Andrási, S. Igaz, Z. Molnár, S. Makó, Disturbances of magnesium concentrations in various brain areas in Alzheimer’s disease. Magnes. Res. 13, 189–196 (2000)
E. Andrási, N. Páli, Z. Molnár, S. Kösel, Brain aluminum, magnesium and phosphorus contents of control and Alzheimer-diseased patients. J. Alzheimer’s Dis. 7, 273–284 (2005). https://doi.org/10.3233/JAD-2005-7402
N. Veronese, A. Zurlo, M. Solmi, C. Luchini, C. Trevisan, G. Bano, E. Manzato, G. Sergi, R. Rylander, Magnesium status in Alzheimer’s disease: a systematic review. Am. J. Alzheimers. Dis. Other Demen. 31, 208–213 (2016). https://doi.org/10.1177/1533317515602674
G. Liu, J.G. Weinger, Z.L. Lu, F. Xue, S. Sadeghpour, Efficacy and safety of MMFS-01, a synapse density enhancer, for treating cognitive impairment in older adults: a randomized, double-blind, placebo-controlled trial. J. Alzheimer’s Dis. 49, 971–990 (2015). https://doi.org/10.3233/JAD-150538
B.C.T. Kieboom, S. Licher, F.J. Wolters, M.K. Ikram, E.J. Hoorn, R. Zietse, B.H. Stricker, M.A. Ikram, Serum magnesium is associated with the risk of dementia. Neurology. 89, 1716–1722 (2017). https://doi.org/10.1212/WNL.0000000000004517
X. Zhu, A.R. Borenstein, Y. Zheng, W. Zhang, D.L. Seidner, R. Ness, H.J. Murff, B. Li, M.J. Shrubsole, C. Yu, L. Hou, Q. Dai, Ca: Mg ratio, APOE cytosine modifications, and cognitive function: results from a randomized trial. J. Alzheimer’s Dis. 75, 85–98 (2020). https://doi.org/10.3233/jad-191223
J. Liu, W. Zhao, E.B. Ware, S.T. Turner, T.H. Mosley, J.A. Smith, DNA methylation in the APOE genomic region is associated with cognitive function in African Americans. BMC Med. Genom. 11, 43 (2018). https://doi.org/10.1186/s12920-018-0363-9
B. Wu, H. Cai, S. Tang, Y. Xu, Q. Shi, L. Wei, L. Meng, N. Zhang, X. Wang, D. Xiao, Y. Zou, X. Yang, X. Li, C. Lu, Methionine-mediated protein phosphatase 2A catalytic subunit (PP2Ac) methylation ameliorates the tauopathy induced by manganese in cell and animal models. Neurotherapeutics. (2020). https://doi.org/10.1007/s13311-020-00930-6
D. Zhu, J. You, N. Zhao, H. Xu, Magnesium regulates endothelial barrier functions through TRPM7, MagT1, and S1P1. Adv. Sci. 6, 1901166 (2019). https://doi.org/10.1002/advs.201901166
C. Smorgon, E. Mari, A.R. Atti, E. Dalla Nora, P.F. Zamboni, F. Calzoni, A. Passaro, R. Fellin, Trace elements and cognitive impairment: an elderly cohort study. Arch. Gerontol. Geriatr. 9, 393–402 (2004). https://doi.org/10.1016/j.archger.2004.04.050
J. Siuda, A. Gorzkowska, M. Patalong-Ogiewa, E. Krzystanek, E. Czech, B. Wiechuła, W. Garczorz, A. Danch, B. Jasińska-Myga, G. Opala, From mild cognitive impairment to Alzheimer’s disease—Influence of homocysteine, vitamin B 12 and folate on cognition over time: Results from one-year follow-up. Neurol. Neurochir. Pol. 43, 321–329 (2009)
C.I. Prodan, L.D. Cowan, J.A. Stoner, E.D. Ross, Cumulative incidence of vitamin B12 deficiency in patients with Alzheimer disease. J. Neurol. Sci. 284, 144–148 (2009). https://doi.org/10.1016/j.jns.2009.05.005
C. Guan, R. Dang, Y. Cui, L. Liu, X. Chen, X. Wang, J. Zhu, D. Li, J. Li, D. Wang, Characterization of plasma metal profiles in Alzheimer’s disease using multivariate statistical analysis. PLoS ONE 12, e0178271 (2017). https://doi.org/10.1371/journal.pone.0178271
S. Rafiee, K. Asadollahi, G. Riazi, S. Ahmadian, A.A. Saboury, Vitamin B12 inhibits tau fibrillization via binding to cysteine residues of tau. ACS Chem. Neurosci. 8, 2676–2682 (2017). https://doi.org/10.1021/acschemneuro.7b00230
N.V. Gorantla, E. Balaraman, S. Chinnathambi, Cobalt-based metal complexes prevent repeat tau aggregation and nontoxic to neuronal cells. Int. J. Biol. Macromol. 152, 171–179 (2020). https://doi.org/10.1016/j.ijbiomac.2020.02.278
K.F. Roberts, C.R. Brue, A. Preston, D. Baxter, E. Herzog, E. Varelas, T.J. Meade, Cobalt(III) Schiff base complexes stabilize non-fibrillar amyloid-β aggregates with reduced toxicity. J. Inorg. Biochem. 213, 111265 (2020). https://doi.org/10.1016/j.jinorgbio.2020.111265
E.A. Bajema, K.F. Roberts, T.J. Meade, Cobalt-schiff base complexes: preclinical research and potential therapeutic uses. Met. Ions Life Sci. NLM (Medline) (2019). https://doi.org/10.1515/9783110527872-017
A.H. Smith, P.A. Lopipero, M.N. Bates, C.M. Steinmaus, Arsenic epidemiology and drinking water standards. Science 296, 2145–2146 (2002). https://doi.org/10.1126/science.1072896
S.S. Tao, P.M. Bolger, Dietary arsenic intakes in the United States: FDA total diet study, September 1991-December 1996. Food Addit. Contam. 16, 465–472 (1999). https://doi.org/10.1080/026520399283759
L. Baum, I.H.S. Chan, S.K.K. Cheung, W.B. Goggins, V. Mok, L. Lam, V. Leung, E. Hui, C. Ng, J. Woo, H.F.K. Chiu, B.C.Y. Zee, W. Cheng, M.H. Chan, S. Szeto, V. Lui, J. Tsoh, A.I. Bush, C.W.K. Lam, T. Kwok, Serum zinc is decreased in Alzheimer’s disease and serum arsenic correlates positively with cognitive ability. Biometals 23, 173–179 (2010). https://doi.org/10.1007/s10534-009-9277-5
B.I. Giasson, D.M. Sampathu, C.A. Wilson, V. Vogelsberg-Ragaglia, W.E. Mushynski, V.M.Y. Lee, The environmental toxin arsenite induces tau hyperphosphorylation. Biochemistry 41, 15376–15387 (2002). https://doi.org/10.1021/bi026813c
N.N. Dewji, C. Do, R.M. Bayney, Transcriptional activation of Alzheimer’s β-amyloid precursor protein gene by stress. Mol. Brain Res. 33, 245–253 (1995). https://doi.org/10.1016/0169-328X(95)00131-B
S. Zarazúa, S. Bürger, J.M. Delgado, M.E. Jiménez-Capdeville, R. Schliebs, Arsenic affects expression and processing of amyloid precursor protein (APP) in primary neuronal cells overexpressing the Swedish mutation of human APP. Int. J. Dev. Neurosci. 29, 389–396 (2011). https://doi.org/10.1016/j.ijdevneu.2011.03.004
S. Gharibzadeh, S.S. Hoseini, Arsenic exposure may be a risk factor for alzheimer’s disease. J. Neuropsychiatry Clin. Neurosci. 20, 501 (2008). https://doi.org/10.1176/jnp.2008.20.4.501
X.L. Li, R.Q. Zhan, W. Zheng, H. Jiang, D.F. Zhang, X.L. Shen, Positive association between soil arsenic concentration and mortality from alzheimer’s disease in mainland China. J. Trace Elem. Med. Biol. 59, 126452 (2020). https://doi.org/10.1016/j.jtemb.2020.126452
M. Edwards, L. Johnson, C. Mauer, R. Barber, J. Hall, S. Obryant, Regional specific groundwater arsenic levels and neuropsychological functioning: a cross-sectional study. Int. J. Environ. Health Res. 24, 546–557 (2014). https://doi.org/10.1080/09603123.2014.883591
S.E. O’Bryant, M. Edwards, C.V. Menon, G. Gong, R. Barber, Long-term low-level arsenic exposure is associated with poorer neuropsychological functioning: a project FRONTIER study. Int. J. Environ. Res. Public Health. 8, 861–874 (2011). https://doi.org/10.3390/ijerph8030861
S. Alboghobeish, M. Pashmforosh, L. Zeidooni, A. Samimi, M. Rezaei, High fat diet deteriorates the memory impairment induced by arsenic in mice: a sub chronic in vivo study. Metab. Brain Dis. 34, 1595–1606 (2019). https://doi.org/10.1007/s11011-019-00467-4
N. Medda, R. Patra, T.K. Ghosh, S. Maiti, Neurotoxic mechanism of arsenic: synergistic effect of mitochondrial instability, oxidative stress, and hormonal-neurotransmitter impairment. Biol. Trace Elem. Res. 198, 8–15 (2020). https://doi.org/10.1007/s12011-020-02044-8
Y.-W. Yang, S.-H. Liou, Y.-M. Hsueh, W.-S. Lyu, C.-S. Liu, H.-J. Liu, M.-C. Chung, P.-H. Hung, C.-J. Chung, Risk of Alzheimer’s disease with metal concentrations in whole blood and urine: a case–control study using propensity score matching. Toxicol. Appl. Pharmacol. 356, 8–14 (2018). https://doi.org/10.1016/j.taap.2018.07.015
C. Garza-Lombó, A. Pappa, M.I. Panayiotidis, M.E. Gonsebatt, R. Franco, Arsenic-induced neurotoxicity: a mechanistic appraisal. J. Biol. Inorg. Chem. 24, 1305–1316 (2019). https://doi.org/10.1007/s00775-019-01740-8
S. Satarug, D.A. Vesey, G.C. Gobe, Health risk assessment of dietary cadmium intake: do current guidelines indicate how much is safe? Environ. Health Perspect. 125, 284–288 (2017). https://doi.org/10.1289/EHP108
K.M. Bakulski, Y.A. Seo, R.C. Hickman, D. Brandt, H.S. Vadari, H. Hu, S.K. Park, Heavy metals exposure and Alzheimer’s disease and related dementias. J. Alzheimers. Dis. 76, 1215–1242 (2020). https://doi.org/10.3233/JAD-200282
H. Li, Z. Wang, Z. Fu, M. Yan, N. Wu, H. Wu, P. Yin, Associations between blood cadmium levels and cognitive function in a cross-sectional study of US adults aged 60 years or older. BMJ Open. 8, e020533 (2018). https://doi.org/10.1136/bmjopen-2017-020533
J.Y. Min, K.B. Min, Blood cadmium levels and Alzheimer’s disease mortality risk in older US adults. Environ. Heal. A Glob. Access Sci. Source. 15, 69 (2016). https://doi.org/10.1186/s12940-016-0155-7
J.R. Bondier, G. Michel, A. Propper, P.M. Badot, Harmful effects of cadmium on olfactory system in mice. Inhal. Toxicol. 20, 1169–1177 (2008). https://doi.org/10.1080/08958370802207292
J.J.V. Branca, M. Maresca, G. Morucci, T. Mello, M. Becatti, L. Pazzagli, I. Colzi, C. Gonnelli, D. Carrino, F. Paternostro, C. Nicoletti, C. Ghelardini, M. Gulisano, L.D.C. Mannelli, A. Pacini, Effects of cadmium on ZO-1 tight junction integrity of the blood brain barrier. Int. J. Mol. Sci. 20, 6010 (2019). https://doi.org/10.3390/ijms20236010
M. Forcella, P. Lau, M. Oldani, P. Melchioretto, A. Bogni, L. Gribaldo, P. Fusi, C. Urani, Neuronal specific and non-specific responses to cadmium possibly involved in neurodegeneration: a toxicogenomics study in a human neuronal cell model. Neurotoxicology. 76, 162–173 (2020). https://doi.org/10.1016/j.neuro.2019.11.002
T.M. Frisoli, R.E. Schmieder, T. Grodzicki, F.H. Messerli, Salt and hypertension: Is salt dietary reduction worth the effort? Am. J. Med. 125, 433–439 (2012). https://doi.org/10.1016/j.amjmed.2011.10.023
D. Mohan, K.H. Yap, D. Reidpath, Y.C. Soh, A. McGrattan, B.C.M. Stephan, L. Robinson, N. Chaiyakunapruk, M. Siervo, Link between dietary sodium intake, cognitive function, and dementia risk in middle-aged and older adults: a systematic review. J. Alzheimers. Dis. 76, 1347–1373 (2020). https://doi.org/10.3233/JAD-191339
E. Koseoglu, R. Koseoglu, M. Kendirci, R. Saraymen, B. Saraymen, Trace metal concentrations in hair and nails from Alzheimer’s disease patients: Relations with clinical severity. J. Trace Elem. Med. Biol. 39, 124–128 (2017). https://doi.org/10.1016/j.jtemb.2016.09.002
K. Higuchi, T. Sato, Y.D. Bhutia, V. Ganapathy, Involvement of a Na+-coupled oligopeptide transport system for β-amyloid peptide (Aβ1–42) in brain cells. Pharm. Res. 37, 98 (2020). https://doi.org/10.1007/s11095-020-02835-7
G. Faraco, K. Hochrainer, S.G. Segarra, S. Schaeffer, M.M. Santisteban, A. Menon, H. Jiang, D.M. Holtzman, J. Anrather, C. Iadecola, Dietary salt promotes cognitive impairment through tau phosphorylation. Nature 574, 686–690 (2019). https://doi.org/10.1038/s41586-019-1688-z
G. Paglia, O. Miedico, A. Cristofano, M. Vitale, A. Angiolillo, A.E. Chiaravalle, G. Corso, A. Di Costanzo, Distinctive pattern of serum elements during the progression of Alzheimer’s disease. Sci. Rep. 6, 22769 (2016). https://doi.org/10.1038/srep22769
B.R. Roberts, J.D. Doecke, A. Rembach, L.F. Yévenes, C.J. Fowler, C.A. McLean, M. Lind, I. Volitakis, C.L. Masters, A.I. Bush, D.J. Hare, Rubidium and potassium levels are altered in Alzheimer’s disease brain and blood but not in cerebrospinal fluid. Acta Neuropathol. Commun. 4, 119 (2016). https://doi.org/10.1186/s40478-016-0390-8
K. Schofield, The metal neurotoxins: an important role in current human neural epidemics? Int. J. Environ. Res. Public Health. 14, 1511 (2017). https://doi.org/10.3390/ijerph14121511
C.E. Cicero, G. Mostile, R. Vasta, V. Rapisarda, S.S. Signorelli, M. Ferrante, M. Zappia, A. Nicoletti, Metals and neurodegenerative diseases. A systematic review. Environ. Res. 159, 82–94 (2017). https://doi.org/10.1016/j.envres.2017.07.048
Acknowledgments
The authors would like to thank the Vice Chancellor for Research and Technology, Kermanshah University of Medical Sciences, for providing suitable conditions to conduct this study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
It is declared that we do not have any conflicts of interest regarding the present study.
Rights and permissions
About this article
Cite this article
Bagheri, S., Saboury, A.A. What role do metals play in Alzheimer's disease?. J IRAN CHEM SOC 18, 2199–2213 (2021). https://doi.org/10.1007/s13738-021-02181-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13738-021-02181-4